Key result
Pulmonary vasodilators used by ~79% of pediatric specialists for left heart disease despite variable criteria.
Why the study?
The use of pulmonary vasodilators in pulmonary hypertension secondary to left heart disease in children is controversial and practice patterns among pediatric PH specialists are variable.
Cross-Sectional (n=47)
Yes
Answers are grounded in this paper and cite their sources.
Variable expert criteria warrant clinical caution in pediatric PH with left heart disease; leaves open need for consensus guidelines and trials.
Development of pulmonary hypertension (PH) in patients with left side heart disease (LHD) is a predictor of poor prognosis. The use of pulmonary vasodilators in PH associated with LHD (PH-LHD) is controversial. In this study, we describe the practice patterns regarding the use of pulmonary vasodilators in PH-LHD among a group of international pediatric PH specialists. A survey was distributed to the members of three pediatric PH networks: PPHNet, PVRI, and REHIPED. The survey queried participants on the rationale, indications, and contraindications of the use of pulmonary vasodilators in children with PH-LHD. Forty-seven PH specialists from 39 PH centers completed the survey. Participants included PH specialists from North America (57%), South America (15%), and Europe (19%). The majority of participants (74%) recommended the use of pulmonary vasodilators only in patients with combined pre-capillary and post-capillary pulmonary hypertension. Participants required the presence of clinical symptoms or signs of heart failure (68%) or right ventricular dysfunction by echocardiography (51%) in order to recommend pulmonary vasodilator therapy. There was no agreement regarding hemodynamic criteria used to recommend pulmonary vasodilators or the etiologies of LHD considered contraindications for using pulmonary vasodilators to manage PH-LHD. Of the available PH-targeted drugs, most participants preferred the use of phosphodiesterase-5-inhibitors for this indication. In conclusion, the practice of recommending pulmonary vasodilators in PH-LHD is highly variable among international pediatric PH specialists. Most specialists of those surveyed (57% in North America) would consider the use of pulmonary vasodilators in PH-LHD only if pre-capillary pulmonary hypertension and right ventricular dysfunction are present.
No takes yet. Share an insight, caveat, or question.
Nawaytou et al. (2021) conducted a cross-sectional in Pediatric pulmonary hypertension secondary to left heart disease (n=47). Pulmonary vasodilators was evaluated on Proportion of specialists who would prescribe pulmonary vasodilators in children with PH-LHD. Among 47 surveyed international pediatric pulmonary hypertension specialists, 79% would prescribe pulmonary vasodilators for children with left heart disease, though criteria for use were highly variable.
Synapse has enriched 10 related papers. Consider them for comparative context: